Cleavable surfactants
US-2023183603-A1 · Jun 15, 2023 · US
US10071960B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-10071960-B1 |
| Application number | US-201715726263-A |
| Country | US |
| Kind code | B1 |
| Filing date | Oct 5, 2017 |
| Priority date | Oct 5, 2017 |
| Publication date | Sep 11, 2018 |
| Grant date | Sep 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present subject matter is directed to an enaminone-grafted trithiocarbonate compound having the structure: and the anticancer and antimicrobial activities exhibited by the compound.
Opening claim text (preview).
We claim: 1. A compound having the formula: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition, comprising the compound according to claim 1 and a pharmaceutically acceptable carrier. 3. A method of treating a disease, comprising: administering to a patient a therapeutically effective amount of the pharmaceutical composition according to claim 2 , wherein the disease is cancer and the cancer is selected from the group consisting of liver cancer, colon cancer, and breast cancer or the disease is a fungal infection. 4. The method of claim 3 , wherein the fungal infection is caused by a yeast or mold. 5. The method of claim 4 , wherein the yeast or mold is Candida albicans. 6. The method of claim 4 , wherein the yeast or mold is Cryptococcus neoformans. 7. The method of claim 4 , where the yeast or mold is Aspergillus fumigatus. 8. The method of claim 4 , where the yeast or mold is Penicillium chrysogenum. 9. The method of claim 3 , wherein the disease fungal infection is caused by a bacteria. 10. The method of claim 9 , wherein the bacteria is Streptococcus mutans. 11. The method of claim 9 , wherein the bacteria is Salmonella typhi. 12. A method of synthesizing a compound, comprising: mixing diethyl 2,2′-(thiocarbonylbis(sulfanediyl))diacetate with N,N′-dimethylformamide dimethyl acetal to form a mixture; and heating the mixture to at least about 100° C. for at least about one hour to form a heated mixture including the compound having the structure: 13. The method of claim 12 , further comprising: allowing the heated mixture to cool to room temperature to form a cooled mixture; maintaining the cooled mixture for at least about 8-10 hours to form a maintained mixture; and isolating the compound from the maintained mixture. 14. The method of claim 13 , wherein the compound is in crystal form. 15. The method of claim 12 , further comprising a preliminary step of reacting ethyl cyanoacetate, carbon disulfide (CS2), and ethyl 2-chloroacetate to synthesize the diethyl 2,2′-(thiocarbonylbis(sulfanediyl))diacetate.
having sulfur atoms of thiocarbonic groups bound to acyclic carbon atoms · CPC title
Thiocarbonic acids; Halides, esters or anhydrides thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.